Source: PHARMABIZ

Theorem Clinical: Chiltern completes acquisition of Theorem Clinical Research

Chiltern, a leading global contract research organisation (CRO), has completed its acquisition of Theorem Clinical Research, strengthening its position as the largest mid─sized provider of comprehensive, yet flexible and responsive, clinical development services.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
John Potthoff's photo - President & CEO of Theorem Clinical

President & CEO

John Potthoff

CEO Approval Rating

89/100

Read more